Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00851669 · ClinicalTrials.gov registry record · Phase 2

The MEADOW PROJECT (Mending the Effects of Alcohol and Depression on Women) and The Bridge Program (Connecting Recovery Treatment and Behavioral Health)

A Phase 2 study of Depression and Alcohol Dependence, sponsored by University of Rochester.

Completed
Registry status
Phase 2
Development phase
91
Enrollment target
1
Study location

NCT00851669: Completed Phase 2 study of Depression and Alcohol Dependence, sponsored by University of Rochester.

NCT00851669 is a Phase 2 study of Depression and Alcohol Dependence that has completed, run by University of Rochester. The registered enrollment target is 91 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00851669, a Phase 2 study of Depression and Alcohol Dependence, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
Phase 2
Development phase
91 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to evaluate an interpersonally-focused intervention (Interpersonal Psychotherapy) for women with co-occurring alcohol dependence and depression. A sub-protocol has been added to pilot the current study with men with co-occurring alcohol dependence and depression.

Interventions

  • BEHAVIORAL Treatment as Usual
  • BEHAVIORAL Interpersonal Psychotherapy for Co-occurring Alcohol Dependence and Major Depression (IPT-ADMD)

Study Locations (1)

New York

  • University of Rochester Medical Center - Rochester

Trial Details

FieldValue
Enrollment Target 91 participants
Start Date 2009-04
Est. Completion 2013-07
Phase Phase 2
University of Rochester

636 total trials

What the finished NCT00851669 record still lists

NCT00851669 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 91 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (88% lower).

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Treatment as Usual is the first listed.

NCT00851669 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT00851669 about?

NCT00851669 is a clinical study titled "The MEADOW PROJECT (Mending the Effects of Alcohol and Depression on Women) and The Bridge Program (Connecting Recovery Treatment and Behavioral Health)". The aim of this study is to evaluate an interpersonally-focused intervention (Interpersonal Psychotherapy) for women with co-occurring alcohol dependence and depression. A sub-protocol has been added to pilot the current study with men with co-occurring alcohol dependence and depression.

What is the current status of trial NCT00851669?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 91 participants. The study started on 2009-04. Estimated completion is 2013-07.

What conditions does trial NCT00851669 study?

This clinical trial studies the following conditions: Depression, Alcohol Dependence.

What interventions are being tested in trial NCT00851669?

The interventions under investigation include: Treatment as Usual (BEHAVIORAL), Interpersonal Psychotherapy for Co-occurring Alcohol Dependence and Major Depression (IPT-ADMD) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00851669?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00851669 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00851669's enrollment target sits among peer trials

91 355th of 679 higher than 324 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02671448 · 91 participants · NA

    Pilot Trial of Homebound Stem Cell Transplantation

  • NCT04835857 · 91 participants

    Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices

  • NCT05184842 · 91 participants · Phase 2

    Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML

  • NCT05685173 · 91 participants · Phase 1

    A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00851669, the US trial registry maintained by the National Library of Medicine. NCT00851669 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.